Measuring and mapping the global burden of antimicrobial resistance
Simon I Hay1,2, Puja C Rao1, Christiane Dolecek3,4
1Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Seattle, WA, 98121, USA.
Abstract:
The increasing number and global distribution of pathogens resistant to antimicrobial drugs is potentially one of the greatest threats to global health, leading to health crises arising from infections that were once easy to treat. Infections resistant to antimicrobial treatment frequently result in longer hospital stays, higher medical costs, and increased mortality. Despite the long-standing recognition of antimicrobial resistance (AMR) across many settings, there is surprisingly poor information about its geographical distribution over time and trends in its population prevalence and incidence. This makes reliable assessments of the health burden attributable to AMR difficult, weakening the evidence base to drive forward research and policy agendas to combat AMR. The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill this policy void.
Insights
Antimicrobial resistance (AMR) poses a significant global health threat, causing difficult-to-treat infections with severe consequences. Better data on AMR
Area of Science:
- Global Health
- Infectious Diseases
- Epidemiology
Background:
- Antimicrobial resistance (AMR) is a growing global health crisis, leading to untreatable infections, prolonged hospital stays, increased costs, and higher mortality rates.
- Despite widespread recognition, there is a significant lack of data on the geographical distribution, temporal trends, prevalence, and incidence of AMR.
Discussion:
- The scarcity of comprehensive AMR data hinders accurate assessment of its health burden.
- This data gap weakens the evidence base required for effective research and policy development to combat AMR.
Key Insights:
- Infections resistant to antimicrobial drugs are a major threat to global health.
- Reliable data on AMR's geographical spread and population trends are critically lacking.
- Accurate burden assessments for AMR are difficult due to poor data availability.
Outlook:
- Integrating mortality and morbidity data from drug-resistant infections into the Global Burden of Disease Study is proposed.
- This integration aims to address the current policy void concerning AMR.
- Improved data collection and reporting are crucial for future AMR mitigation strategies.
Related Concept Videos
Global Climate Change
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Resistivity
Resistance
Introduction to Global Positioning System


